Scott Dalgleish is Chief Financial Officer of Oncology Institute, Inc.. Currently has a direct ownership of 151,008 shares of TOI, which is worth approximately $22,651. The most recent transaction as insider was on Mar 21, 2022, when has been sold 32,092 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 151K
0% 3M change
0% 12M change
Total Value Held $22,651

Scott Dalgleish Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 21 2022
BUY
Grant, award, or other acquisition
-
32,092 Added 17.53%
151,008 Common Stock
Nov 12 2021
BUY
Grant, award, or other acquisition
-
118,916 Added 50.0%
118,916 Common Stock
SD

Scott Dalgleish

Chief Financial Officer
Cerritos, CA

Track Institutional and Insider Activities on TOI

Follow Oncology Institute, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TOI shares.

Notify only if

Insider Trading

Get notified when an Oncology Institute, Inc. insider buys or sells TOI shares.

Notify only if

News

Receive news related to Oncology Institute, Inc.

Track Activities on TOI